The growth rate of the consumer healthcare business could accelerate now that an activist investor is involved.
(Reuters) -Hedge fund Starboard Value has taken a stake in Kenvue, the consumer products company that makes Band-Aid, ...
Jefferies analyst Keith Devas initiated coverage with a Buy rating on Kenvue, Inc. (KVUE – Research Report) today and set a price target ...
Kenvue shares jumped premarket after The Wall Street Journal reported that Starboard Value has taken a sizable stake in the ...
Haleon was spun off from GSK amid investor pressure, showing steady growth but facing debt concerns. See more about HLN stock ...
Activist investor Starboard Value reportedly has taken a large stake in consumer health products maker Kenvue.
Kenvue, Inc. (KVUE – Research Report), the Technology sector company, was revisited by a Wall Street analyst yesterday. Analyst Anna ...
Starboard Chief Executive Jeff Smith said that Kenvue, the Tylenol-maker spun out from Johnson & Johnson, should drill down on fixing its underperforming skin health and beauty segment, which he ...
Financial writer highlights activist investor Starboard Value's push for Kenvue (KVUE) to divest its challenged skin, ...
Activist investor Starboard Value, which picked up a $1 billion stake in Pfizer earlier this month, now reportedly has ...
On Tuesday, Kenvue Inc (KVUE) stock saw a modest uptick, ending the day at $22.93 which represents a slight increase of $0.01 or 0.04% from the prior close of $22.92. The stock opened at $22.55 and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback